Overview

Neurovascular Complications and White Matter Damage in Acquired Anemias

Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This is an observational trial, with an interventional arm, in patients with moderate to severe anemia and control subjects. The main purpose of this study is to understand whether normal brain blood flow, oxygen extraction reserve, white matter volumes, and brain functional connectivity are affected by acquired anemia. We will perform baseline MRI monitoring for all subjects. Subjects with confirmed iron defiency will be offered intravenous iron therapy. Repeat MRI will be performed twice following iron replacement therapy. All eligible subjects will be asked to provide informed consent before participating in the study.
Phase:
Early Phase 1
Details
Lead Sponsor:
Children's Hospital Los Angeles
Treatments:
Ferric Compounds